Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice

✍ Scribed by Tahara, Atsuo; Kurosaki, Eiji; Yokono, Masanori; Yamajuku, Daisuke; Kihara, Rumi; Hayashizaki, Yuka; Takasu, Toshiyuki; Imamura, Masakazu; Li, Qun; Tomiyama, Hiroshi; Kobayashi, Yoshinori; Noda, Atsushi; Sasamata, Masao; Shibasaki, Masayuki

• Book ID: 120368598
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 842 KB
• Volume: 715
• Category: Article
• ISSN: 0014-2999
• DOI: 10.1016/j.ejphar.2013.05.014